COMPANY

NOK Therapeutics

noktx.com ↗

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Form D reports $3K sold since 2024 (filed Mar 26, 2026; amended May 1, 2026); +2 other Form D filings in the last 12 months. SEC Form D 0001213900-26-034315 (Mar 26, 2026)
Evidence (3 events)
- Mar 26, 2026 · SEC Form D 0001213900-26-034315
  Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D; Filing date: 2026-03-26; Industry Group: Biotechnology; Date of First Sale: 2024-06-27; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1400; Total Amount Sold: 1400; Federal exemptions: 06b || Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D/A; Filing date: 2026-04-22; Industry Group: Biotechnology; Date of First Sale: 2024-06-27; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 1400; Total Amount Sold: 1400; Federal exemptions: 06b || Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D/A; Filing date: 2026-05-01; Industry Group: Biotechnology; Date of First Sale: 2024-06-11; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 3200; Total Amount Sold: 3200; Federal exemptions: 06b
- Oct 24, 2025 · SEC Form D 0001213900-25-102039
  Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp, PA; Submission type: D; Filing date: 2025-10-24; Industry Group: Biotechnology; Date of First Sale: 2024-10-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 250500; Federal exemptions: 06b || Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D/A; Filing date: 2026-04-22; Industry Group: Biotechnology; Date of First Sale: 2024-10-08; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 500500; Federal exemptions: 06b || Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D/A; Filing date: 2026-05-01; Industry Group: Biotechnology; Date of First Sale: 2024-09-24; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 750500; Federal exemptions: 06b
- Oct 24, 2025 · SEC Form D 0001213900-25-102036
  Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D; Filing date: 2025-10-24; Industry Group: Biotechnology; Date of First Sale: 2024-08-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 750000; Total Amount Sold: 566500; Federal exemptions: 06b || Name of Issuer: Nok Therapeutics, Inc.; CIK: 2038166; Address: Cranberry Twp., PA; Submission type: D/A; Filing date: 2026-04-22; Industry Group: Biotechnology; Date of First Sale: 2024-08-06; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 750000; Total Amount Sold: 649000; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals